Search Results 151-160 of 17557 for Immune thrombocytopenia
Treating an underlying disease, such as an infection or cancer. Other treatments might involve: Medicines. If thrombocytopenia is related to an immune system ...
Learn which doctors and departments treat Immune thrombocytopenia (ITP) at Mayo Clinic.
... Immune Thrombocytopenia (ITP). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...
Immune thrombocytopenia (ITP) is a condition in which the immune system destroys platelets, the blood cells that help stop bleeding. Large granular lymphocyte ( ...
Research. Mayo Clinic researchers study what can cause immune thrombocytopenia (ITP) and new ways to treat it. Publications. See a list of publications ...
The purpose of this study is to evaluate the effectiveness and safety of PANZYGA in pediatric patients with chronic Immune Thrombocytopenia (ITP). Participation ...
The study drug will be administered orally in participants with Primary Immune Thrombocytopenia (ITP). Blood tests will be performed to check how much ...
Fostamatinib is used to treat low platelet levels (thrombocytopenia) in the blood in patients with chronic immune thrombocytopenia (ITP) who have received ...
Study Of Ianalumab Versus Placebo In Addition To First-line Corticosteroids In Primary Immune Thrombocytopenia (ITP) (VAYHIT1) · Share · Facebook · Twitter.
The main purpose of this study is to look at the effect (efficacy) and safety of efgartigimod IV in participants with primary immune thrombocytopenia (ITP).
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.